Solabegron Uses, Dosage, Side Effects and more
Solabegron (GW-427,353) is a selective β3 adrenoceptor agonist being developed for the treatment of overactive bladder and irritable bowel syndrome.
| Attribute | Details |
|---|---|
| Trade Name | Solabegron |
| Generic | Solabegron |
| Solabegron Other Names | Solabegron |
| Type | |
| Formula | C23H23ClN2O3 |
| Weight | Average: 410.9 Monoisotopic: 410.1397203 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in diabetes mellitus type 2, irritable bowel syndrome (IBS), and urinary incontinence.
Innovators Monograph
Search Medicines
